Visual Universitätsmedizin Mainz

Kongressbeiträge (Vortrags-Auswahl)

  1. Hepatic insulin signaling is inhibited by CYP2E1 overexpression. 26.10.2003, Boston, AASLD 2003.
  2. Jnk1 promotes the development of steatohepatitis from a methionine and choline deficient diet. 31.10.2004, Boston, AASLD 2004.
  3. CYP2E1-induzierter chronisch oxidativer Stress inhibiert Insulin Signaltransduktion in Hepatozyten. 02.09.2004, Leipzig, DGVS 2004.
  4. FADD promotes the development of steatohepatitis involving c-Jun N-terminal kinase signaling (JNK). 28.04.2006, Wien, EASL 2006.
  5. Loss of FLIP in hepatocytes promotes cell death from oxidative stress involving MAPK signaling, San Francisco, 02.11.2008, AASLD 2008.
  6. Ablation of c-FLIP augments CD95- and Gal/LPS-induced injury through JNK activation. 24.04.2008, Mailand, EASL 2008.
  7. Epidemiology and risk factors for metabolic syndrome and non-alcoholic fatty liver disease, 10.10.2008, Istanbul, IASGO 2008.
  8. Deletion von c-Flip in Hepatozyten fördert oxidativ-induzierte Zellschädigung durch Suppression von Erk, 24.10.2008, Bad Kreuznach, GARPS, 2008.
  9. Mouse Models of NAFLD: of Mice and Man. 18.10.2009, Hannover, FALK Symposium 171.
  10. Hepatocyte specific deletion of FLIP renders mice more susceptible to Concanavalin A induced hepatitis. 02.11.2009, San Francisco, AASLD 2009.
  11. NASH aktuell - Das Spektrum der nicht-alkoholische Steatohepatitis, 10.04.2010, Wiesbaden, 16. FALK Symposium Aktuelle Hepatologie.
  12. The caspase-8 homologue cFLIP modulates hepatocarcinogenesis in mice. 16.04.2010, Wien, EASL 2010.